Man Group’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-21,543
| Closed | -$196K | – | 2051 |
|
|
2024
Q1 | $196K | Buy |
+21,543
| New | +$196K | ﹤0.01% | 1879 |
|
|
2023
Q4 | – | Hold |
0
| – | -$50.3K | – | 2066 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 1836 |
|
|
2022
Q1 | – | Sell |
-106,970
| Closed | -$746K | – | 2131 |
|
|
2021
Q4 | $746K | Buy |
+106,970
| New | +$746K | ﹤0.01% | 1404 |
|
|
2020
Q1 | – | Sell |
-760,490
| Closed | -$3M | – | 1772 |
|
|
2019
Q4 | $3M | Sell |
760,490
-1,148,988
| -60% | -$4.54M | 0.01% | 1188 |
|
|
2019
Q3 | $5.81M | Sell |
1,909,478
-248,671
| -12% | -$756K | 0.02% | 804 |
|
|
2019
Q2 | $9.5M | Buy |
2,158,149
+434,693
| +25% | +$1.91M | 0.03% | 650 |
|
|
2019
Q1 | $6.84M | Buy |
1,723,456
+535,948
| +45% | +$2.13M | 0.03% | 745 |
|
|
2018
Q4 | $4.73M | Buy |
1,187,508
+684,391
| +136% | +$2.72M | 0.02% | 790 |
|
|
2018
Q3 | $3.46M | Buy |
+503,117
| New | +$3.46M | 0.01% | 1178 |
|